DSIP vs Epithalon: two different mechanisms, two different patients Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide that acts directly on sleep centers in the brain to initiate sleep onset and increase non-REM sleep time
Additionally, the growing obesity cases is also increasing the demand for GLP-1 receptor agonists, where the presence of the advanced healthcare sector is also increasing their adoption rates
Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Its clinical trial participants lost an average of 20% of their body weight within a year and a half of starting treatment
A responsible plan reviews sleep, stress load, hormones, medications, neurologic history, and whether any specific option is appropriate or legally available for the patients situation
FDA drug labeling, Mounjaro (tirzepatide) prescribing information California Medi-Cal excluded weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) effective January 1, 2026 Mounjaro's diabetes coverage is unaffected
